| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $20.5M | -5.7% |
| Cost of Revenue | $10.4M | +4.4% |
| Gross Profit | $10.1M | -14.2% |
| R&D Expense | $16.0M | -26.2% |
| SG&A Expense | $10.8M | +1.9% |
| Operating Income | -$10.8M | +47.0% |
| Pre-tax Income | -$10.5M | +47.5% |
| Income Tax | $130K | +85.7% |
| Net Income | -$10.6M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | -6.9% |
| Accounts Receivable | $3.2M | +1.6% |
| Inventory | $3.9M | -21.8% |
| Current Assets | $23.5M | -22.1% |
| Total Assets | $43.3M | +2.0% |
| Current Liabilities | $7.1M | +31.9% |
| Total Liabilities | $15.1M | +132.4% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | +25.2% |
| Capital Expenditures | $45K | -93.0% |
| Investing Cash Flow | $11.3M | +311.1% |
| Financing Cash Flow | $633K | -65.0% |
| Free Cash Flow | -$13.0M | +27.6% |
| +47.0% |
| EPS (Basic) | -$0.42 | +47.5% |
| EPS (Diluted) | -$0.42 | +47.5% |
| Stockholders' Equity |
| $28.2M |
| -21.5% |